Form 4: Columbia Financial Inc. Executive Schlesinger Reports Stock Transactions
SEC Form 4 Filing
Allyson Katz Schlesinger, SEVP & Head of Consumer Banking at Columbia Financial, Inc., reports acquisition of common stock and stock options.
Summary
- Allyson Katz Schlesinger, a Senior Executive at Columbia Financial, Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report includes the acquisition of common stock through a stock-based deferral plan at a price of $13.95 per share.
- Schlesinger also holds stock options with exercise prices of $15.60, $15.94, and $16.49, which vest in installments.
- The report details direct and indirect ownership of common stock through various plans including an ESOP, SERP, and stock awards.
- The filing indicates holdings of 58,434 shares of common stock directly and various amounts indirectly through different plans.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document is a standard regulatory filing detailing stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Positives
- The executive's continued participation in stock-based compensation plans demonstrates alignment with shareholder interests.
- The vesting schedules of stock options and awards incentivize long-term performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be an indicator of management's confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages including stock options and awards are common in the financial services industry to align management incentives with shareholder value.
- Companies like JP Morgan Chase, Bank of America, and Wells Fargo also utilize equity-based compensation plans for their executives.
Stakeholder Impact
- Shareholders can use this information to understand executive compensation and alignment with company performance.
- Employees participating in the ESOP or other stock-based plans are affected by the value of the company's stock.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Commencement date for vesting of stock options with an exercise price of $15.60. |
| 05/01/2024 | Commencement date for vesting of stock options with an exercise price of $15.94 and stock awards II. |
| 06/14/2024 | Date of common stock acquisition through stock-based deferral plan. |
| 06/18/2024 | Date of signature for the report. |
| 03/06/2025 | Commencement date for vesting of stock options with an exercise price of $16.49 and stock awards III. |
| 07/23/2029 | Expiration date for stock options with an exercise price of $15.60. |
| 05/01/2033 | Expiration date for stock options with an exercise price of $15.94. |
| 03/06/2034 | Expiration date for stock options with an exercise price of $16.49. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.